Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gsk Plc ADR
(NY:
GSK
)
41.40
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
13,754
Open
41.40
Bid (Size)
41.18 (5)
Ask (Size)
41.20 (8)
Prev. Close
41.40
Today's Range
41.40 - 41.40
52wk Range
33.67 - 45.92
Shares Outstanding
5,385,189,617
Dividend Yield
3.49%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
New European Regulations Could Hinder Rare Disease Treatments, Pharma Industry Raises Concerns Over Stricter Clinical Trial Rules
August 13, 2024
Pharmaceutical companies, researchers, and patient groups are voicing concerns over new EU regulations that could hinder rare disease treatment development by imposing stricter guidelines on medical...
Via
Benzinga
Performance
YTD
+10.37%
+10.37%
1 Month
+6.43%
+6.43%
3 Month
-7.75%
-7.75%
6 Month
-0.89%
-0.89%
1 Year
+18.12%
+18.12%
More News
Read More
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
August 12, 2024
Via
Benzinga
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Release Promising Clinical Data As Global Alzheimer’s Disease Therapeutics Market Grows
August 07, 2024
Via
Investor Brand Network
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
July 29, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Is GSK a Top-Value Stock Right Now?
July 17, 2024
Via
The Motley Fool
Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
August 06, 2024
From
Myriad Genetics, Inc.
Via
GlobeNewswire
Lucrative Incentive for Biotechs as Global Alzheimer’s Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
August 06, 2024
Via
FinancialNewsMedia
Lucrative Incentive for Biotechs as Global Alzheimer's Disease Therapeutics Market Forecasted to Reach $30.8 Billion By 2033
August 06, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
August 05, 2024
Via
Investor's Business Daily
Moderna Stock Trading Lower On Dismal Guidance, Analysts Cuts Price Targets Noting Competitive Pressure From GSK, Pfizer
August 02, 2024
Via
Benzinga
Exposures
COVID-19
US FDA expands Jemperli (dostarlimab-gxly) plus chemotherapy approval to all adult patients with primary advanced or recurrent endometrial cancer as the first and only immuno-oncology-based treatment to show an overall survival benefit
August 01, 2024
From
GSK plc
Via
Business Wire
British Pharma Giant GSK's Blockbuster Shingles And Respiratory Syncytial Virus Vaccine Q2 Sales Miss Expectations, Cuts Annual Vaccine Revenue Guidance
July 31, 2024
Via
Benzinga
Topics
Earnings
Exposures
Financial
GSK Beats Second-Quarter Views, Raises Outlook; But Shares Fall On Shingrix Miss
July 31, 2024
Via
Investor's Business Daily
GSK Stock Earnings: GSK Beats EPS, Beats Revenue for Q2 2024
July 31, 2024
Via
InvestorPlace
Tech Stocks On Track For Best Session In 5 Months Ahead Of Fed Meeting; Small Caps Target Highest Close Since January 2022: What's Driving Markets Wednesday?
July 31, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
GSK's Top Selling Vaccine Can Potentially Reduce Dementia Risk, Research Suggests
July 26, 2024
Via
Benzinga
Wall Street Remains On Track For AMD-Led Rebound Ahead Of Fed Decision, Meta Earnings: Analyst Says 'The Bull Tends To Remain' Despite Near-Time Volatility
July 31, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial
July 23, 2024
Via
Benzinga
3 Stocks Under $10 With the Potential for Massive Gains
July 22, 2024
Via
InvestorPlace
Top Research Reports For Apple, Lowe's & Shopify
July 17, 2024
Via
Talk Markets
European Commission Faces Court Criticism Over COVID Vaccine Contract Transparency Ahead Of Vote on Ursula Von Der Leyen's Reappointment
July 17, 2024
Via
Benzinga
Exposures
COVID-19
3 Top Cancer Treatment Stocks to Buy Now
July 17, 2024
Via
InvestorPlace
Positive News is Driving This Cancer Drug Maker’s Stock Higher
July 15, 2024
Via
MarketBeat
The 3 Most Undervalued Pharma Stocks to Buy in July 2024
July 12, 2024
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.